Objective: Sickle cell disease (SCD) is a chronic condition affecting over 100 000 individuals in the United States, predominantly from vulnerable populations. Clinical practice guidelines, written for providers, have low adherence. This study explored knowledge about guidelines; desire for guidelines; and how technology could support guideline awareness and adherence, examining current technology uses, and user preferences to inform design of a patient-centered guidelines application in a chronic disease. Methods: This cross-sectional mixed-methods study involved semi-structured interviews, surveys, and focus groups of adolescents and adults with SCD. We evaluated interest, preferences, and anticipated benefits or barriers of a patient-centered adaptation of SCD practice guidelines; prospective technology uses for health; and barriers to technology utilization. Results: Forty-seven individuals completed surveys and interviews, and 39 participated in three separate focus groups. Most participants (91%) were unaware of SCD guidelines, but almost all (96%) expressed interest in a guidelines application, identifying benefits (knowledge, activation, individualization, and rewards), and barriers (poor information, low motivation, and resource limitations). Current technology health uses included information access, care coordination, and reminders about health-related actions. Prospective technology uses included informational messaging and timely alerts. Barriers to technology use included lack of interest, lack of utility, and preference for direct communication.
INTRODUCTION
Sickle cell disease (SCD) is a hereditary hemoglobin disorder that affects over 100 000 Americans, primarily from vulnerable populations of lower socioeconomic status and from racial or ethnic minorities. 1, 2 The acute and chronic complications of SCD substantially impact both affected individuals' health and utilization of healthcare services. Adults with SCD account for 197 000 emergency room visits per year and, on average, each accrue $900 000 in lifetime costs of care by age 45. [3] [4] [5] As with most chronic conditions, such as hypertension, diabetes, and asthma, clinicians' care of SCD (including health maintenance, treatment, and prevention of complications) is informed by clinical practice guidelines. 6 However, poor guideline utilization or adherence is a common barrier to the long-term health of individuals with chronic conditions, [7] [8] [9] including SCD. [10] [11] [12] [13] [14] [15] Examples of poor SCD guideline adherence include the utilization of hydroxyurea therapy in only 20%-30% of eligible individuals, and the 45% completion rate of annual stroke screening among eligible children. [15] [16] [17] Traditionally, guidelines are written for clinicians, guiding their disease management instructions to patients. However, patients, through their behaviors, are most directly responsible for acting in accordance with the guidelines. While technologies are increasingly used to support knowledge and self-management in individuals with chronic conditions like SCD, no studies have considered technology as a means to deliver patient-centered guidelines for chronic disease management. [18] [19] [20] [21] [22] [23] [24] [25] [26] A "guidelines technology" is a potential opportunity in consumer health informatics to leverage commonly used modalities to educate, engage, and activate patients, improving their involvement in evidence-based decision-making and care. Optimizing care using technology could be particularly beneficial, but possibly challenging, in a predominantly vulnerable population with multiple comorbidities, such as SCD. To address these consumer health informatics gaps, this study sought to assess the SCD community's interest in clinical practice guidelines, and how individuals with SCD could use technology to be informed about guidelines, engage in shared decision-making surrounding their care, and thereby support adherence to guideline recommendations. To understand benefits and barriers to technologies for improving patient adherence to clinical practice guideline recommendations, we used the Health Belief Model (HBM) as our theory for health behavior decision-making ( Figure 1) . [27] [28] [29] According to the HBM, engagement in a health behavior depends upon an individual's perceptions of 4 parameters: (1) susceptibility, the risk of experiencing disease or its effect(s); (2) severity, the seriousness of the condition or its consequences; (3) benefits, the anticipated positive outcomes of a behavior on disease risk or burden; and (4) barriers, the costs or adverse effects of a health behavior, and the possible difficulties or deterrents preventing its completion. These parameters are also influenced by patient-specific demographic, psychological, and socioeconomic determinants of behavior, as well as other modifying factors such as cues to action and self-efficacy. Considering the challenges with under-utilization of, or nonadherence to, clinical practice guidelines, and the high rates of technology penetration among demographic groups over-represented in the SCD population (e.g., younger age, low socioeconomic status, and racial or ethnic minority background), we believe a patient-centered application adapting recommendations of the 2014 Evidence-Based Management of Sickle Cell Disease Expert Panel Report could support awareness of and adherence to guidelines for individuals with SCD, as well as engage these individuals to have conversations with their providers. 6, 30 To inform application design, we conducted a cross-sectional mixed-methods study using semi-structured interviews, surveys, and focus groups, evaluating if individuals with SCD know about guidelines; whether they would want these guidelines; and the perceived benefits and barriers to, as well as preferences for, a proposed application for access and adherence to SCD guidelines. In addition, we assessed individuals' use of technology to obtain health information and support disease management practices. These inquiries were guided by the HBM, which we applied to assess the factors influencing individuals' willingness to use health information technologies to support consequent engagement in health-related actions.
OBJECTIVES
The research questions in this study were as follows:
( 
METHODS

Study Instruments
This mixed-methods study involved 2 phases: (1) semi-structured interviews and surveys and (2) focus groups. These instruments were created by members of the research team and SCD clinicians, then tested by a few individuals with SCD prior to conducting the study. The semi-structured interview was comprised of fixed-choice and open-ended questions regarding individuals' preferences for an adaptation of clinical practice guidelines for individuals with SCD use. Specific questions included: (1) prior awareness of the guidelines; (2) interest in guideline access and use; (3) preferred formats for receiving guidelines, such as electronic vs paper form, self-guided viewing vs explanation by a clinician, and favored technological means of access; (4) anticipated benefits in SCD care from guideline use; (5) perceptions of how technology could facilitate guideline adherence; and (6) anticipated barriers to guideline use.
The survey consisted of free-text and multiple-choice items about participant demographics and consumer technology use, including patient portals, text messaging, mobile applications, social media, websites, and online discussion groups or forums. Surveys asked about purposes of current or previous technology use in health and non-health contexts, interest in use for health, and anticipated purposes or goals of such use.
The focus group centered on preferences for technology to acquire health information; current and prospective uses of technology for disease management; and barriers to use of technology for disease management.
We applied the HBM to guide questions regarding preferences for application design to promote guideline adherence. The interview and focus group elicited perceived benefits and barriers to guideline application use. The interview and survey explored how respondents use technology to access information for SCD management, which frames their understanding of disease severity and susceptibility and therefore modifies health behaviors. Cues to action and self-efficacy were evaluated through interview questions on whether, and how, technology could facilitate guideline adherence and improve self-care.
Population, Setting, and Procedure
For the survey and interview phase, we enrolled a separate cohort of adolescents and adults aged 12-70 years who had a diagnosis of SCD and were prescribed daily medications such as hydroxyurea. Participants were selected among individuals seen in adult and pediatric outpatient clinics affiliated with the Vanderbilt-Meharry Center for Excellence in SCD (Nashville, TN) from September 2016 to July 2017, using a convenience sampling method. Individuals with SCD were consented for participation during routine clinic appointments, then scheduled to complete the in-person survey and interview at a later date. Participants unable to complete surveys or interviews (e.g., due to severe cognitive dysfunction limiting responses to questions) were excluded. We administered the survey to each participant using a Research Electronic Data Capture survey on a laptop computer. 31 Study subjects were asked to complete missing items or clarify free-text items where appropriate. Afterwards, each participant completed a semi-structured interview, conducted according to an interview guide. Interviews were recorded, then transcribed and de-identified for analysis. We also conducted 3 focus groups involving adults with a diagnosis of SCD or SCD trait. Participants were recruited through the Sickle Cell Foundation of Tennessee, a community-based organization. Recruitment strategies included flyers and emails to identify potential participants. Focus groups were conducted by a facilitator using a written moderator's guide. The groups were audio recorded, then transcribed and de-identified for analysis.
The research protocol and all study materials were reviewed and approved by the institutional review board before participant enrollment and data collection were initiated.
Analysis
An inductive-deductive, qualitative content analysis approach was used to identify emerging themes. 32 Two members of the research team (AU, RMC) reviewed 10 interview transcripts to identify themes and develop a list of terms (i.e., a codebook). We initially used an open-coding methodology, recording all codes that emerged from the data. 33, 34 Once we had an initial set of concepts, we condensed them into summative themes, then modified the codebook to associate themes to the component(s) of the HBM with which they most closely corresponded (e.g., recognizing the "knowledge" theme as reinforcing perceptions of severity or susceptibility). As additional transcripts were coded and new themes emerged, the codebook was iteratively refined and earlier transcripts recoded according to codebook revisions. All themes corresponded to an HBM component. 
RESULTS
Participants Were Primarily Adults Representing a Broad Range of Socioeconomic Characteristics
For the surveys and interviews, we approached 81 adolescents and adults with SCD meeting the study inclusion-exclusion criteria. Of those approached, 75 of 81 participants (93%) were enrolled in the study, from which 47 of 75 individuals (63%) completed the interview and survey, including one partial response. Participant characteristics are presented in Table 1 . The study population had a median age of 28.0 years (range: 14-61), was predominantly Black (92%) and a majority had Hemoglobin SS genotype (57%). They had a relatively even distribution of genders (47% male, 53% female) and education levels, and were primarily lower-income (64% with individual annual income <$45 000). Focus group participants included 39 adults (ages 18 and over) with SCD or SCD trait. Participant characteristics are presented in Table 1 , including 2 partial responses. The focus group population had a median age of 44.8 years (range: 25-66) years, was predominantly female (79%) and had Hemoglobin SS, SC, or AS genotype (27%, 24%, and 21%, respectively). They represented a broad range of educational and income levels.
Respondents Generally do not Know About Guidelines, but after Learning about Them, They Want to Access Them in Multiple Ways Forty-seven respondents-including one partial responsecompleted the interview regarding interest in and preferences for a patient-facing adaptation of the clinical practice guidelines outlined in the 2014 Evidence-Based Management of Sickle Cell Disease Expert Panel Report. 6 Only 4 respondents (9%) reported prior awareness of the guidelines or their contents. However, 44 (96%) expressed interest in learning about the content of the guidelines, either through explanation from a healthcare provider (n ¼ 39, 85%), a paper copy of the guidelines (n ¼ 33, 72%), or an electronic version of the guidelines (n ¼ 38, 83%). Among the 38 participants requesting an electronic version of the guidelines, the most preferred modalities were email (n ¼ 33, 87%), a mobile application (n ¼ 25, 66%), a patient portal (n ¼ 22, 58%), a website (n ¼ 16, 42%), and social media (n ¼ 9, 24%).
Respondents Have Insights into Potential Benefits, Barriers, and Attributes of Technology for Guidelines Awareness and Adherence
The qualitative analysis of focus group and interview transcripts identified respondents' perspectives on the potential benefits of a guideline application to support SCD care, barriers to application use or guideline adoption, and preferred attributes to promote anticipated benefits or mitigate possible barriers in a guideline application ( Table 2 ). The primary themes are summarized below. Benefit 1: Increased knowledge of disease and management strategies. Respondents anticipated that a guidelines application would augment their knowledge of SCD, including relevant aspects of its pathophysiology, signs/symptoms, treatment, health maintenance, and potential complications. Users requested information in understandable language [R17] and a format they could easily access and use [R22, R28], reasoning that improved knowledge of SCD and the biomedical basis of symptoms or self-care actions would strengthen motivation or self-efficacy for guideline fulfillment. In addition to using information for their own education, participants also wanted to share information to educate caregivers or clinicians who may be unfamiliar with the guidelines [R20, FG]. Benefit 3: Individualized guidance in SCD management. Individuals with SCD anticipated that a guidelines application would support their autonomy and agency in SCD care planning, allowing them to understand their options for treatment and health maintenance interventions and make decisions with their clinician [R30]. They could then validate their clinician's advice in the context of academic literature or consensus standards of care [R24], and personalize application settings, like preferred information formats or reinforcing strategies, to execute those decisions [R20, R05]. These advantages were projected to reinforce adherence to care and empower users to be active participants, rather than passive recipients, in their care.
Benefit 4: Rewards for guideline adherence. Respondents supported instituting rewards for fulfilling guideline-derived objectives. Proposed incentives included material benefits [R24]; gamification elements, like points systems or competitions [R23]; expected health improvements from application use and guideline adherence [R29]; or negative consequences for nonadherence [R27] . Notably, a subset of respondents expressed firm opposition to material rewards, stating that health status, rather than incentives, ought to be a sufficient standalone motivator of application use and guideline adherence. These strong, yet polarized responses, underscore that applications must be tailored to individuals' preferences. . Therefore, even if the user was provided adequate information, the application might not elicit sufficient motivation to convert information into actions.
Barrier 3: External limitations to fulfillment of guidelines. The final user-proposed barrier was the possibility of external deterrents or constraints preventing adherence to guidelines. If a user had limited ability to undertake the recommended actions (e.g., caregiving obligations, transportation difficulties, low income) [R43, FG, R10]; lacked the technology access or fluency required to use an 
Many Individuals with SCD use Technologies for General Purposes only, but Want to use These Technologies for Their Health
Self-identified current health-related uses of technology differed by technological modality (Table 3 ). Health uses of mobile apps and patient portals were primarily related to accessing information, like SCD educational materials or disease-relevant health news, and viewing or coordinating one's own care, such as medications, appointments, test results, and personal health records. Text messaging was used for freeform communication with clinicians or caregivers and alerts or reminders about health-related actions (e.g., appointments or medication use, pickup, or refills). Social media and discussion forums were used to exchange information, experiences with illness and its care, and supportive messages with other individuals with SCD.
There were many prospective applications of technology to fulfill health-specific tasks or objectives (Table 3) . Participants wanted to use mobile apps to look up disease-related information, receive reminders, communicate and track their health with their clinician, and engage in their care including filling out health related forms and scheduling medical appointments. Participant-suggested prospective uses for text messaging included an expanded range of informational messaging and timed alerts, and included motivational prompts to support self-care actions, patient education articles, or health tips. Prospective applications of social media and discussion forums included communication with clinicians or receipt of health news, educational materials, or self-care instructions. Interest in communication with one's SCD clinician or caregivers was a consistent preference in current or prospective use across almost all modalities. Some uses (identified by an asterisk) were identified as both current and prospective uses, potentially reflecting differing awareness or adoption of currently available uses among respondents.
Concerns or deterrents to health-related technology use were similar across modalities (Table 3) . These included lack of interest in the technology, inability to identify use cases, and preference for face-to-face or synchronous communication. Additional modalityspecific concerns or barriers included technical difficulties with patient portal access or use; perception of text messaging and social media as "unprofessional" methods of communication with a clinician; and, for social media and discussion forums, concerns about information credibility, relevance, and privacy.
DISCUSSION
This study is one of the first to describe a lack of awareness of clinical practice guidelines among individuals with chronic disease; desire to access such guidelines; and preferences for an application to adapt clinician-oriented clinical practice guidelines into a patientcentered format conducive to adherence. Most patients in this study were not aware that relevant guidelines existed, but once informed, expressed strong interest in receiving and using them. We examined patients' preferred features in a guidelines application, the benefits they would want to receive from a guideline-based application, and the barriers that might limit application use or guideline adherence. These findings can guide development of an SCD guidelines application and potentially inform comparable technologies for other chronic conditions. This study further explored use, willingness to use, and barriers to adoption of different technology platforms for health-related purposes in this vulnerable population, which can further inform the design of technologies to deliver guidelines to patients.
The framework of the HBM helped identify benefits, barriers, and attributes about a guideline-based application (Figure 2 ). Individuals with SCD expressed interest in an intervention that would provide information about the SCD guidelines, including the actions that individuals with SCD should take; the benefits of guideline adherence and subsequent health implications for the user (benefits of and barriers to action); and the likelihood (susceptibility) and burden (severity) of SCD complications. Respondents expressed a preference for instructional or motivational alerts, interactions with A user wants to know how pregnancy would affect her SCD. She searches for the keyword "pregnancy" in the guidelines application, and finds instructions for SCD care in pregnancy that are communicated using lay-friendly terms, images, and links to supplemental videos or documents A user wants to learn more about SCD, but does not want to read the guidelines in their entirety. He enables daily application notifications, which share short-form summaries of key guideline topics Alerts and cues Use cues to promote awareness and adherence to health behaviors A user is experiencing a pain episode. She logs this episode in the application, which presents her pain action plan that helps her manage her pain, and a section about how to talk with her healthcare provider about her pain A user sets a goal in the application to take hydroxyurea daily. If he has not logged a day's medication use by evening, a mobile notification is sent Social interaction Facilitate interactions with patients' support network, like caregivers or other people with their disease A user's clinician has advised that she start iron chelation therapy. She references the guidelines for iron chelation, which include a link to connect to a social media application or community organization website. There, she can ask other patients about their experiences with this medication Shared decision-making (with providers) Facilitate interactions with patients' care team, as well as clinicians who have not cared for them before A user has an acute complication of SCD, like acute priapism. He selects this from a list of emergencies to notify his caregiver and clinician. The application advises him to go to an ER if it is prolonged, and shows him guidelines that he can share with an ER physician who might be unfamiliar with SCD care for priapism Decision support Help patients understand the choices available to them in the guidelines, and offer tools and resources to assess the benefits, risks, costs, and personal factors that frame each choice A user is curious about hydroxyurea therapy. She accesses the guidelines application to review its indications in patient-friendly language. She also reviews infographics and pictographs that compare its risks and benefits A user is unsure of his physician's advice to start chronic transfusions.
He reads the guidelines to understand the strength, and basis, of this recommendation Integration with personal preferences Personalize, or allow users to customize, the guidelines application to provide information or cues that fit their own health status, sociodemographic traits, health literacy or activation level, or individual habits and preferences A user who does not usually get transfusions has a low hemoglobin and reticulocyte count on a recent lab result. Since he has set a preference in the application to receive notifications via text message, he receives a text alert that he now has an indication for transfusion, with a link to the guidelines A young adult user wants his parents to help him with his guideline adherence. He adds them as "caregivers" on the application, so that they can receive alerts when he meets, or does not meet, guidelinelinked goals clinicians or caregivers, or interactive prompts for a user response (cues to action) that, collectively, translate awareness of guidelines into adherence to their recommendations (self-efficacy). In the HBM, health behaviors are influenced by modifying variables specific to each individual. Consistent with this tenet, respondents voiced a need for the guidelines application to provide personalized guidance and support choice of individuals with SCD in their care. These insights into individuals' preferences reflect their habits and objectives for technology aids in SCD care, and are significant considerations to inform the design of a guideline-based application and other information technology applications for SCD management. Our recommendations for application design, derived from respondents' preferences, are outlined in Table 4 .
Other studies have described adaptations of evidence-based information to support education and disease management, such as "lay language" guideline versions or self-management information technologies, but have not explored how technology might improve access and utility of guidelines. [35] [36] [37] We expand upon this work by exploring a technology adaptation of chronic disease clinical practice guidelines to support guideline awareness, adherence, and shared decision-making in a primarily vulnerable patient population. The qualitative findings in our study concur with patientreported benefits of guideline access in previous studies, including accessing lay-friendly instructions; understanding and exercising options in disease management; informing patients to facilitate decision-making in partnership with clinicians; and offering a "second opinion" to validate their clinician's guidance. 35, [38] [39] [40] [41] [42] [43] [44] Similarly, our identified barriers mirror potential challenges of patientcentered guidelines studied in other diseases and formats, like reluctance to question one's clinician, disagreement with guidelines, or insufficient time or resources to implement guidelines. 35, 45 Our findings can be used to mitigate these barriers, which may be more pronounced in SCD due to socioeconomic barriers, mistrust of healthcare providers, and concerns regarding safety and efficacy of mainstay therapies. [46] [47] [48] [49] Additionally, respondents' preferences for application design reflect common principles for design of chronic disease self-management applications (e.g., easily readable and accessible information, instructions and alerts for self-care actions, self-tracking or goal monitoring, motivational prompts or feedback, incentives or rewards, and interaction with support figures or clinicians). 24, [50] [51] [52] [53] [54] [55] [56] [57] [58] These findings suggest that a guidelines application, relative to conventional patient-centered guidelines, may be advantageous for leveraging technology features to make guidelines more engaging and interactive, and therefore potentially more impactful for use and adherence. Another unique finding in our study is patients' emphasis on shared decision-making and desire to use this guideline technology to educate others who may not know guidelines content, including clinicians with limited experience or training related to their condition (Tables 3 and 4 ). There are examples of clinicians not knowing or being comfortable with chronic disease guidelines. 9, 26 Informing patients about the most recent evidence may allow them to collaborate with clinicians and promote evidence-based care, but may also introduce challenging interactions if the clinician is unfamiliar with, or disagrees with, the guidelines. This new shared decision-making dynamic is an area that will require future research. Our assessment of respondents' current and prospective technology uses is consistent with prior studies in confirming that individuals with SCD report a strong desire to adopt new technologies or programs to support their health-related objectives and goals. 24, [59] [60] [61] [62] Participants used technology for a variety of health purposes and had many ideas for potential uses, but also voiced concerns about technologies. They used some technologies for educational purposes, communication, exchanging experiences, self-management, and viewing or coordinating one's own care, such as medications, appointments, test results, and personal health records. Participants had concerns about multiple technology platforms, including access, technical difficulties, and a lack of benefit. Social media applications for health produced more concerns than other technologies, primarily attributable to respondents' privacy concerns and the perception of social media as a social or recreational tool, not a health or education resource (Table 3) . These results showed current use and desire to use technology for their health in a variety of ages of individuals with SCD, including those who may not be as technology-savvy as the adolescents and young adults studied previously. 24, 62 This finding is particularly important in the context of recent improvements in life expectancy of individuals with SCD, as these technologies will, in the near future, support care for individuals with SCD of increasingly diverse ages and varied levels of technical literacy. There were several limitations to this study. Our results were based upon a convenience sample from Tennessee and was complicated by a moderate rate of loss to follow-up; therefore, the technology usage and preferences of our sample may not be generalizable. These cautions were somewhat mitigated by the observation that our sample's preferences for information technology in SCD care were consistent with those found in previous studies. 24, 62 In addition, individuals who do not follow up for research activities are likely those not adhering to guidelines, and all of these studies may underrepresent their perspectives. Furthermore, we were not able to evaluate the quantitative relationships between specific participant characteristics and technology usage or preferences due to a small study sample. However, this study's main objectives were primarily descriptive and exploratory, intended to generate hypotheses, and it appropriately lays the groundwork for subsequent studies to confirm these hypotheses with tests of significance. Finally, our study relied on self-report measures of technology use and respondents' perceptions of their technology needs; therefore, actual use characteristics or preferences may differ from those articulated in this study.
CONCLUSION
This study provides evidence that individuals with SCD, a chronic condition predominantly affecting a vulnerable population, have limited knowledge of clinical practice guidelines written for clinician use, but once informed, have strong interest in accessing and using such guidelines to manage their disease. Patients with SCD also exhibit interest in use of a patient-centered guideline application, with consistently desired features of easily accessible, actionable information to support decision-making; behavioral cues and alerts; interactions with caregivers and patient support networks; and personalization for individual traits or preferences. Preferences for some functions, such as rewards or social interactions, were more mixed, underscoring the necessity for a customizable application design. Patients also describe a desire to use these guidelines to educate clinicians who may not know as much about their disease. This new shift in the shared-decision making dynamic, in which patients sometimes know more than their clinicians, will need careful consideration and research to prevent strained patient-clinician relationships and deliver the best care for patients. As technologies continue to rapidly evolve, patients' willingness to use innovative tools for disease management should be considered in application design. Our findings augment consumer health informatics literature by providing direction for future efforts to design a guideline application, or other information technologies that can engage and activate patients for disease management or shared decision-making. Future studies might extend upon these results by incorporating the identified qualitative themes into subsequent interventions and evaluating user feedback or pilot trial outcomes. These findings could also be applied to guidelines applications in other chronic diseases-particularly, although not exclusively, conditions primarily affecting young and/or vulnerable populations. Likewise, subsequent research should build upon the descriptive foundations presented in this study to more precisely characterize the participant characteristics that predict certain types of technology use, or certain preferences for technology design, helping clinicians connect individuals with chronic disease with the technologies and features that best suit their personal needs, interests, and goals.
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